Lupin receives FDA approval for Fluoxetine Tablets

India |  News | 0 Comment | 13 Feb, 2019

Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States Food and Drug Administration (FDA) to market a generic version of Alv...Read more

Dr. Reddy's launches Tadalafil Tablets in US

India |  News | 0 Comment | 12 Feb, 2019

Dr. Reddy’s Laboratories has announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tadalafil) Tablets in the United States market, a...Read more

Glenmark receives ANDA approval for Sevelamer Hydrochloride Tablets

India |  News | 0 Comment | 11 Feb, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Ren...Read more

Kiran Mazumdar Shaw inducted to the National Academy of Engineering

India |  News | 0 Comment | 08 Feb, 2019

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon Ltd has been elected as a member of the prestigious U.S.-based National Academy of Engineering (NAE) for her contribution to t...Read more

Lupin announces launch of NaMuscla

India |  News | 0 Comment | 04 Feb, 2019

India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdom (UK). NaMuscla® is approved across the European Union (EU) for ...Read more

Dermozone to launch its +dalethyne based skincare products in India

India |  News | 0 Comment | 01 Feb, 2019

Indonesia-based Dermozone, a renowned wound healing and skincare products company, has announced its plans to shortly launch in India a total of five ‘+dalethyne’ based skincare...Read more

The Stop TB Partnership, India Health Fund to roll out new people-centered TB innovations in India

India |  News | 0 Comment | 31 Jan, 2019

The Stop TB Partnership and the Confluence for Health Action and Transformation Foundation (“India Health Fund”) has signed a Memorandum of Understanding (MOU) in Geneva. This M...Read more

Ziqitza to bring up $40 million for its expansion

India |  News | 0 Comment | 28 Jan, 2019

Ziqitza Healthcare Ltd.(JHL), India's second-largest emergency medical services provider, is planning to raise around $40 million from private equity investors. The company is in talks with...Read more

WHO employs directors for Western Pacific and Southeast Asia regions

India |  News | 0 Comment | 28 Jan, 2019

The WHO has appointed Dr Takeshi Kasai as Regional Director for WHO’s Western Pacific Region, and re-appointed Dr Poonam Khetrapal Singh for a second term as Regio...Read more

Cipla receives approval for Pfizer’s Depo-Provera

India |  News | 0 Comment | 28 Jan, 2019

Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Medroxyprogesterone Injectable, 150mg/mL from the United S...Read more

Apollo inaugurates South East Asia's first Proton Cancer Centre

India |  News | 0 Comment | 25 Jan, 2019

India's first multi-speciality chain of hospitals, today opened the Apollo Proton Cancer Centre (APCC), giving cancer patients access to a specialised form of radiotherapy that is extr...Read more

Dr. Reddy's brings Propofol injectable emulsion in US market

India |  News | 0 Comment | 25 Jan, 2019

Dr. Reddy’s Laboratories Ltd. has launched the Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of DIPRIVAN (propofol) Injectable Emulsion, USP, approv...Read more

Glenmark receives tentative ANDA approval for Topiramate

India |  News | 0 Comment | 24 Jan, 2019

Glenmark Pharmaceuticals Inc., has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100...Read more

Zydus gets tentative USFDA approval for acid reflux capsules

India |  News | 0 Comment | 22 Jan, 2019

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The company has received the tentative...Read more

Lupin receives FDA approval for Levothyroxine Sodium Tablets

India |  News | 0 Comment | 22 Jan, 2019

Indian Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg, 75 mcg,  88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg...Read more

Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma

India |  News | 0 Comment | 18 Jan, 2019

Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also...Read more

RHT Health completes disposal of entire asset portfolio

India |  News | 0 Comment | 17 Jan, 2019

The Trustee-Manager of RHT Health Trust is pleased to announce that the Disposal was completed recently. Following Completion, FHML, HEPL, IHL and EHSSHL have ceased to be subsidiaries of R...Read more

Two Indian startups make it to Merck's innovation centre

India |  News | 0 Comment | 17 Jan, 2019

Merck, a leading science and technology company, has recently announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Centre in...Read more